ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,940Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 6645

$995K Total Retail Price of All Prescriptions

Rank: 326 out of 6645

531 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 531 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 20,487 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 997 919 1 3
NAMENDA 970 970 2 41
DONEPEZIL HCL 842 842 3 27
OMEPRAZOLE 832 744 4 6
AMLODIPINE BESYLATE 799 759 5 2
LEVOTHYROXINE SODIUM 792 765 6 4
SIMVASTATIN 690 633 7 1
METFORMIN HCL 659 607 8 7
FUROSEMIDE 532 482 9 11
HYDROCODONE-ACETAMINOPHEN 475 440 S3 10 5
WARFARIN SODIUM 423 414 11 16
LOSARTAN POTASSIUM 423 400 11 12
PRAVASTATIN SODIUM 420 395 13 20
CARVEDILOL 393 372 14 25
HYDROCHLOROTHIAZIDE 385 374 15 9
METOPROLOL TARTRATE 385 378 15 13
ATORVASTATIN CALCIUM 355 332 17 10
METOPROLOL SUCCINATE 343 340 18 24
CITALOPRAM HBR 332 295 19 35
SERTRALINE HCL 319 273 20 43
DIOVAN 257 240 21 19
RISPERIDONE 251 251 22 93
GABAPENTIN 243 214 23 18
METFORMIN HCL ER 230 217 24 89
ALENDRONATE SODIUM 230 230 24 14
POTASSIUM CHLORIDE 209 200 26 28
TAMSULOSIN HCL 206 196 27 22
FAMOTIDINE 201 193 28 33
POLYETHYLENE GLYCOL 3350 180 166 29 121
ISOSORBIDE MONONITRATE ER 175 173 30 66
RIVASTIGMINE 174 174 31 363
LOSARTAN-HYDROCHLOROTHIAZIDE 171 158 32 62
MIRTAZAPINE 171 170 32 70
TRAMADOL HCL 167 139 34 30
FLUTICASONE PROPIONATE 162 160 35 26
LANTUS 158 149 36 50
GLIMEPIRIDE 154 135 37 47
BUMETANIDE 139 132 38 267
JANUVIA 131 107 39 38
PANTOPRAZOLE SODIUM 129 129 40 29
ACTOS 129 105 40 71
ATENOLOL 127 123 42 8
ROPINIROLE HCL 124 103 43 166
CLOPIDOGREL 117 107 44 36
CRESTOR 116 79 45 34
SPIRONOLACTONE 107 101 46 85
LEVETIRACETAM 107 84 46 119
ALLOPURINOL 106 89 48 31
FELODIPINE ER 106 102 48 105
EXELON 104 92 50 149
ABILIFY 92 45 51 204
CARBIDOPA-LEVODOPA 92 92 51 116
VENLAFAXINE HCL ER 88 86 53 175
LYRICA 86 73 54 127
PREDNISONE 86 86 54 57
BENAZEPRIL HCL 84 83 56 21
LACTULOSE 81 74 57 125
DIGOXIN 80 78 58 59
LANTUS SOLOSTAR 77 76 59 139
METOCLOPRAMIDE HCL 77 77 59 120
SPS 75 73 61 538
AMIODARONE HCL 74 74 62 160
METHOTREXATE 72 72 63 217
TRIAMCINOLONE ACETONIDE 70 63 64 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 58 65 37
PROAIR HFA 65 61 66 32
NORTRIPTYLINE HCL 64 59 67 171
NIASPAN 64 53 67 164
ADVAIR DISKUS 63 60 69 45
FENTANYL 62 62 S2 70 141
CHLORTHALIDONE 58 58 71 180
NOVOLOG 58 55 71 144
ONGLYZA 57 56 73 168
LABETALOL HCL 57 51 73 226
PIOGLITAZONE HCL 54 48 R 75 184
ESCITALOPRAM OXALATE 54 54 75 86
PLAVIX 53 47 77 49
VENLAFAXINE HCL 52 52 78 388
TERAZOSIN HCL 52 52 78 48
OXYBUTYNIN CHLORIDE ER 50 50 80 179
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 47 80 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.